Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Macular Degeneration Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Macular Degeneration Drugsmarket, defines the market attractiveness level of Macular Degeneration Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Macular Degeneration Drugs industry, describes the types of Macular Degeneration Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Macular Degeneration Drugs market and the development prospects and opportunities of Macular Degeneration Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Macular Degeneration Drugs market in Chapter 13.
By Player:
Neurotech Pharmaceuticals
Allergan
Novartis
Bayer Healthcare
Regeneron Pharmaceuticals
Roche
By Type:
Lucentis
Eylea
Avastin
Squalamine
Conercept
Lampalizamab
Other
By End-User:
50-60 Years Old
60-70 Years Old
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Macular Degeneration Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Macular Degeneration Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Macular Degeneration Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Macular Degeneration Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Macular Degeneration Drugs Market Analysis and Outlook to 2022
-
7.1 Global Macular Degeneration Drugs Consumption (2017-2022)
-
7.2 United States Macular Degeneration Drugs Consumption (2017-2022)
-
7.3 Europe Macular Degeneration Drugs Consumption (2017-2022)
-
7.4 China Macular Degeneration Drugs Consumption (2017-2022)
-
7.5 Japan Macular Degeneration Drugs Consumption (2017-2022)
-
7.6 India Macular Degeneration Drugs Consumption (2017-2022)
-
7.7 South Korea Macular Degeneration Drugs Consumption (2017-2022)
8 Region and Country-wise Macular Degeneration Drugs Market Analysis and Outlook to 2028
-
8.1 Global Macular Degeneration Drugs Consumption Forecast (2022-2028)
-
8.2 United States Macular Degeneration Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Macular Degeneration Drugs Consumption Forecast (2022-2028)
-
8.4 China Macular Degeneration Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Macular Degeneration Drugs Consumption Forecast (2022-2028)
-
8.6 India Macular Degeneration Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Macular Degeneration Drugs Consumption Forecast (2022-2028)
9 Global Macular Degeneration Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Macular Degeneration Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Lucentis Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Eylea Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Avastin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Squalamine Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Conercept Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Lampalizamab Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Macular Degeneration Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global 50-60 Years Old Consumption and Growth Rate (2017-2022)
-
9.2.2 Global 60-70 Years Old Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Macular Degeneration Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Macular Degeneration Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Lucentis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Eylea Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Avastin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Squalamine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Conercept Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Lampalizamab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Macular Degeneration Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global 50-60 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global 60-70 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Macular Degeneration Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Macular Degeneration Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Macular Degeneration Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Macular Degeneration Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Macular Degeneration Drugs Market Competitive Analysis
-
14.1 Neurotech Pharmaceuticals
-
14.1.1 Neurotech Pharmaceuticals Company Details
-
14.1.2 Neurotech Pharmaceuticals Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Neurotech Pharmaceuticals Macular Degeneration Drugs Product and Service
-
14.2 Allergan
-
14.2.1 Allergan Company Details
-
14.2.2 Allergan Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Allergan Macular Degeneration Drugs Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Macular Degeneration Drugs Product and Service
-
14.4 Bayer Healthcare
-
14.4.1 Bayer Healthcare Company Details
-
14.4.2 Bayer Healthcare Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bayer Healthcare Macular Degeneration Drugs Product and Service
-
14.5 Regeneron Pharmaceuticals
-
14.5.1 Regeneron Pharmaceuticals Company Details
-
14.5.2 Regeneron Pharmaceuticals Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Regeneron Pharmaceuticals Macular Degeneration Drugs Product and Service
-
14.6 Roche
-
14.6.1 Roche Company Details
-
14.6.2 Roche Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Roche Macular Degeneration Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Macular Degeneration Drugs
-
Figure Macular Degeneration Drugs Picture
-
Table Global Macular Degeneration Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Macular Degeneration Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Macular Degeneration Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Macular Degeneration Drugs Consumption by Country (2017-2022)
-
Figure United States Macular Degeneration Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Macular Degeneration Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Macular Degeneration Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Macular Degeneration Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Macular Degeneration Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Macular Degeneration Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Macular Degeneration Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Macular Degeneration Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Macular Degeneration Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Macular Degeneration Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Macular Degeneration Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Macular Degeneration Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Macular Degeneration Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lucentis Consumption and Growth Rate (2017-2022)
-
Figure Global Eylea Consumption and Growth Rate (2017-2022)
-
Figure Global Avastin Consumption and Growth Rate (2017-2022)
-
Figure Global Squalamine Consumption and Growth Rate (2017-2022)
-
Figure Global Conercept Consumption and Growth Rate (2017-2022)
-
Figure Global Lampalizamab Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 50-60 Years Old Consumption and Growth Rate (2017-2022)
-
Figure Global 60-70 Years Old Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Lucentis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Eylea Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Avastin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Squalamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Conercept Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lampalizamab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 50-60 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 60-70 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Macular Degeneration Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Macular Degeneration Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Neurotech Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Neurotech Pharmaceuticals Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neurotech Pharmaceuticals Macular Degeneration Drugs Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Macular Degeneration Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Macular Degeneration Drugs Product and Service
-
Table Bayer Healthcare (Foundation Year, Company Profile and etc.)
-
Table Bayer Healthcare Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Healthcare Macular Degeneration Drugs Product and Service
-
Table Regeneron Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Macular Degeneration Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Macular Degeneration Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Macular Degeneration Drugs Product and Service
-
